Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
$606K Buy
6,662
+439
+7% +$45.3K 0.02% 641
2023
Q2
$701K Buy
6,223
+450
+8% +$47.6K 0.03% 485
2023
Q1
$604K Sell
5,773
-238
-4% -$24.9K 0.03% 480
2022
Q4
$665K Buy
6,011
+1,233
+26% +$129K 0.04% 445
2022
Q3
$417K Buy
+4,778
New +$434K 0.03% 505

Other funds holding XYL

Advisor Partners II's XYL Position: Q3 2023 in Review

Advisor Partners II increased its Xylem (XYL) stake by 7.1% in Q3 2023, buying an estimated $45.3K and bringing the position to 6,662 shares worth $606K. The position accounts for 0.02% of the portfolio, ranked #641.

Advisor Partners II first reported a position in XYL in Q3 2022 and has held it in 5 quarters since. The position peaked at $701K in Q2 2023. 872 funds tracked by Wall St. Rank hold XYL as of Q3 2023.

  • Advisor Partners II held 6,662 shares of Xylem worth $606K as of Q3 2023.
  • Advisor Partners II bought 439 Xylem shares in Q3 2023, an estimated $45.3K.
  • Xylem made up 0.02% of Advisor Partners II's portfolio in Q3 2023, its #641 holding.
  • Advisor Partners II first reported a position in Xylem in Q3 2022 and has held it in 5 quarters since.
  • Advisor Partners II's Xylem position peaked at $701K in Q2 2023.
  • 872 funds tracked by Wall St. Rank held Xylem as of Q3 2023.

Based on Advisor Partners II's 13F filing for Q3 2023, filed 26 Oct 2023.